A.D.H.D. Startup Executives Accused of $100 Million Fraud in Adderall Scheme
Tens of thousands of patients with attention deficit hyperactivity disorder nationwide could face disruptions to their care after two executives of a major telehealth company that distributed A.D.H.D. drugs were indicted on charges of health care fra... [1374 chars]
Source: The New York Times
